{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:39:22Z","timestamp":1782563962554,"version":"3.54.5"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The review provides updates on novel risk markers for the development of pediatric inflammatory uveitis and a severe disease course, on treatment of refractory disease, and on the measurement of visual outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>There are several new genetic markers, biomarkers, and clinical factors that may influence a child's uveitis disease course. It is important to identify children at risk for poor visual outcomes and who are refractory to traditional therapy. Racial disparities have recently been reported. We describe agents of potential benefit. In addition, we discuss the importance of patient reported outcomes in this population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Uveitis can lead to vision-threatening complications. Timely and aggressive treatment of children identified to be at risk for a severe uveitis course may lead to improved outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000316","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T19:12:40Z","timestamp":1466622760000},"page":"544-549","source":"Crossref","is-referenced-by-count":33,"title":["Uveitis in children"],"prefix":"10.1097","volume":"28","author":[{"given":"Sheila T.","family":"Angeles-Han","sequence":"first","affiliation":[{"name":"Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo Egla","family":"Rabinovich","sequence":"additional","affiliation":[{"name":"Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12969-015-0018-8","article-title":"Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis","volume":"13","author":"Angeles-Han","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"R2-20230828","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","article-title":"Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the systemic immunosuppressive therapy for eye diseases study","volume":"120","author":"Gregory","year":"2013","journal-title":"Ophthalmology"},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","article-title":"Epidemiology and course of disease in childhood uveitis","volume":"116","author":"Smith","year":"2009","journal-title":"Ophthalmology"},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ajo.2008.11.009","article-title":"Chronic anterior uveitis in children: clinical characteristics and complications","volume":"147","author":"Holland","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R5-20230828","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ajo.2006.11.025","article-title":"Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis","volume":"143","author":"Woreta","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1172\/JCI109872","article-title":"Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody","volume":"66","author":"Glass","year":"1980","journal-title":"J Clin Invest"},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.81.11.3539","article-title":"Inherited predisposition to iridocyclitis with juvenile rheumatoid arthritis: selectivity among HLA-DR5 haplotypes","volume":"81","author":"Miller","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-20230828","first-page":"1394","article-title":"Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis","volume":"18","author":"Giannini","year":"1991","journal-title":"J Rheumatol"},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3476(05)82541-7","article-title":"Human leukocyte antigen-DRB1\u22171104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis","volume":"121","author":"Melin-Aldana","year":"1992","journal-title":"J Pediatr"},{"key":"R10-20230828","first-page":"160","article-title":"The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients","volume":"19","author":"Malagon","year":"1992","journal-title":"J Rheumatol"},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1167\/iovs.15-17168","article-title":"HLA associations in a cohort of children with juvenile idiopathic arthritis with and without uveitis","volume":"56","author":"Angeles-Han","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12969-015-0037-5","article-title":"The common NOD2\/CARD15 variant P268S in patients with noninfectious uveitis: a cohort study","volume":"13","author":"Marrani","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.92.2.295","article-title":"American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis","volume":"92","year":"1993","journal-title":"Pediatrics"},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1167\/iovs.12-10865","article-title":"Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis","volume":"54","author":"Kalinina Ayuso","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ajo.2014.11.007","article-title":"Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis","volume":"159","author":"Haasnoot","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1167\/iovs.15-17351","article-title":"Infiltration of plasma cells in the iris of children with ANA-positive anterior uveitis","volume":"56","author":"Kalinina Ayuso","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/art.1780240914","article-title":"Localization of IgM in plasma cells in the iris of a patient with iridocyclitis and juvenile rheumatoid arthritis","volume":"24","author":"Godfrey","year":"1981","journal-title":"Arthritis Rheum"},{"key":"R18-20230828","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ophtha.2008.03.027","article-title":"Immunohistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis","volume":"115","author":"Parikh","year":"2008","journal-title":"Ophthalmology"},{"key":"R19-20230828","first-page":"733","article-title":"Ocular histopathology in juvenile rheumatoid arthritis","volume":"11","author":"Sabates","year":"1979","journal-title":"Ann Ophthalmol"},{"key":"R20-20230828","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1167\/iovs.15-17066","article-title":"Elevated S100A8\/A9 and S100A12 serum levels reflect intraocular inflammation in juvenile idiopathic arthritis-associated uveitis: results from a pilot study","volume":"56","author":"Walscheid","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-20230828","doi-asserted-by":"crossref","DOI":"10.1002\/art.39621","article-title":"Ocular fluid analysis in children reveals interleukin-29\/interferon-\u03bb1 as a biomarker for juvenile idiopathic arthritis associated uveitis","author":"Haasnoot","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3899\/jrheum.150567","article-title":"Autoantibodies to dense fine speckles in pediatric diseases and controls","volume":"42","author":"Schmeling","year":"2015","journal-title":"J Rheumatol"},{"key":"R23-20230828","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.22709","article-title":"Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor","volume":"56","author":"Saurenmann","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02751522","article-title":"Juvenile rheumatoid arthritis in India: rarity of antinuclear antibody and uveitis","volume":"63","author":"Aggarwal","year":"1996","journal-title":"Indian J Pediatr"},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12969-015-0030-z","article-title":"Epidemiology of juvenile idiopathic arthritis in Oman","volume":"13","author":"Abdwani","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"R26-20230828","first-page":"510","article-title":"Juvenile chronic arthritis in black and Indian South African children","volume":"65","author":"Haffejee","year":"1984","journal-title":"S Afr Med J"},{"key":"R27-20230828","first-page":"1826","article-title":"Juvenile rheumatoid arthritis in African Americans","volume":"24","author":"Schwartz","year":"1997","journal-title":"J Rheumatol"},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10067-010-1401-y","article-title":"Juvenile idiopathic arthritis among Nigerians: a case study","volume":"29","author":"Adelowo","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3899\/jrheum.130302","article-title":"Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry","volume":"40","author":"Angeles-Han","year":"2013","journal-title":"J Rheumatol"},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ajo.2015.08.002","article-title":"The association of race with childhood uveitis","volume":"160","author":"Angeles-Han","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2015.06.041","article-title":"The risk of intraocular pressure elevation in pediatric noninfectious uveitis","volume":"122","author":"Kothari","year":"2015","journal-title":"Ophthalmology"},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol Int"},{"key":"R33-20230828","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of antitumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"R34-20230828","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","article-title":"Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus","volume":"35","author":"Bou","year":"2015","journal-title":"Rheumatol Int"},{"key":"R35-20230828","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2015.09.036","article-title":"Outcome of treating pediatric uveitis with dexamethasone implants","volume":"161","author":"Tomkins-Netzer","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R36-20230828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12969-016-0069-5","article-title":"Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry","volume":"14","author":"Henderson","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.140410","article-title":"Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis","volume":"42","author":"Tappeiner","year":"2015","journal-title":"J Rheumatol"},{"key":"R38-20230828","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00417-015-3140-x","article-title":"Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series","volume":"253","author":"Marrani","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R39-20230828","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","article-title":"Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis","volume":"100","author":"Miserocchi","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/acr.22613","article-title":"Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry","volume":"67","author":"Foeldvari","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R41-20230828","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/acr.22649","article-title":"Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a nationwide pediatric rheumatology database","volume":"68","author":"Tappeiner","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R42-20230828","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2010.08.021","article-title":"Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis","volume":"151","author":"Ayuso","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R43-20230828","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaapos.2013.06.004","article-title":"Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report","volume":"17","author":"Saboo","year":"2013","journal-title":"J AAPOS"},{"key":"R44-20230828","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3899\/jrheum.121180","article-title":"Response of pediatric uveitis to tumor necrosis factor-alpha inhibitors","volume":"40","author":"Lerman","year":"2013","journal-title":"J Rheumatol"},{"key":"R45-20230828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1546-0096-11-16","article-title":"Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis","volume":"11","author":"Simonini","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"R46-20230828","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R47-20230828","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13023-015-0318-6","article-title":"Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis","volume":"10","author":"Denniston","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"R48-20230828","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/acr.21674","article-title":"Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood","volume":"64","author":"Heiligenhaus","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R49-20230828","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaapos.2009.12.160","article-title":"The importance of visual function in the quality of life of children with uveitis","volume":"14","author":"Angeles-Han","year":"2010","journal-title":"J AAPOS"},{"key":"R50-20230828","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/acr.20524","article-title":"Development of a vision-related quality of life instrument for children ages 8\u201318 years for use in juvenile idiopathic arthritis-associated uveitis","volume":"63","author":"Angeles-Han","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R51-20230828","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/acr.22627","article-title":"Using the effects of youngsters\u2019 eyesight on quality of life questionnaire to measure visual outcomes in children with uveitis","volume":"67","author":"Angeles-Han","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201609000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T05:30:58Z","timestamp":1693200658000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201609000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000316","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}